Protein A - 80nm Gold NanoUrchins
Cytodiagnostics
SKU:GUAC-80-05-05
Couldn't load pickup availability

Protein A - 80nm Gold NanoUrchins for NanoUrchin-based assays
Protein A - 80nm Gold NanoUrchins supports method development where compatible immunoglobulins through Protein A binding must be detected in Immunoblotting, Light Microscopy and Electron Microscopy. It helps researchers evaluate target fit, assay readout and control strategy before selecting a related label or antibody format.
Where it helps
Its NanoUrchin morphology supports red-shifted plasmon behavior and enhanced optical response compared with spherical particles of similar core size. This mid-range NanoUrchin size balances visible signal with practical handling in membrane-based and microscopy workflows.
Planning the experiment
- Supports Immunoblotting, Light Microscopy and Electron Microscopy workflows where Protein A signal needs to be interpreted with appropriate controls.
- Useful when the primary antibody class is compatible with Protein A binding and a species-independent detection strategy is desired.
- Include matched negative controls and optimize blocking to separate true target-associated signal from nonspecific particle binding.
Reference GUAC-80-05-05 in protocols, purchasing notes and internal reagent libraries when matching this product to your chosen assay. For protocol transfer, record the catalog reference together with the selected application and control strategy.
- Research Area:
- Bioconjugation & Labeling • Assay Development • Nanotechnology & Biosensors
- Application:
- Immunoblotting • Light Microscopy • Electron Microscopy
- Host:
- S. Aureus
- Formulation:
- 0.5XPBS (pH 7.4), 20% glycerol (v/v), 1% BSA
- Adsorption Max:
- 620nm
- Core Size:
- 80nm
- Shape:
- Urchin
- Material:
- Gold
- Storage Temperature:
- 4°C
For Research Use Only. Not intended for diagnostic or therapeutic use.
Products may be subject to intellectual property rights.
The purchase of this product does not grant any license for commercial use, manufacturing, or clinical applications. The user is responsible for ensuring compliance with applicable laws and third-party rights.